Digital Therapeutics Market - Global Forecast 2026-2032

The Digital Therapeutics Market is projected to reach USD 7.37 Billion in 2026. It is expected to continue growing at a CAGR of 15.92%, reaching USD 18.05 Billion by 2032.

Digital therapeutics (DTx) are evidence-based software interventions designed to prevent, manage, or treat disease, often used independently or alongside medication, devices, and clinician-led care. The category is moving from wellness-adjacent apps toward regulated medical software supported by randomized clinical trials, real-world evidence, cybersecurity controls, interoperability standards, and reimbursement pathways.

Demand is being reinforced by durable health system pressures: chronic disease prevalence, behavioral health shortages, aging populations, and the need to extend care beyond hospitals and clinics. Verified policy signals, including FDA oversight of software as a medical device, Germany’s DiGA pathway, the U.K.’s DTAC framework, France’s PECAN early access pathway for digital medical devices, and U.S. remote therapeutic monitoring codes, show that digital therapeutics are becoming a formal part of connected care infrastructure.

Transformative Shifts in the Digital Therapeutics Landscape

The digital therapeutics landscape is shifting from direct-to-consumer experimentation to enterprise adoption by providers, payers, employers, pharmaceutical stakeholders, and public health systems. Buyers increasingly require clinical validation, health economic evidence, workflow integration, usability testing, data security, and measurable outcomes before scaling solutions across populations.

A second shift is the convergence of DTx with telehealth, remote patient monitoring, electronic health records, pharmacy services, and value-based care contracts. This integration is changing the competitive benchmark: successful platforms must not only engage patients, but also deliver longitudinal data, clinician decision support, adherence insights, and compliance with privacy, accessibility, and medical device regulations.

Cumulative Impact of Artificial Intelligence on Digital Therapeutics

Artificial intelligence is amplifying the value of digital therapeutics by enabling adaptive interventions, personalized coaching, risk stratification, natural-language engagement, and automated escalation to care teams. AI can help match intervention intensity to patient behavior, comorbidities, social risk factors, and response patterns, improving the relevance of therapy between clinical visits.

The cumulative impact is also increasing regulatory and governance expectations. Industry leaders must validate AI models across diverse populations, monitor algorithm drift, document clinical safety, protect health data, and maintain explainability where outputs affect treatment. Responsible AI is becoming a competitive differentiator as payers, providers, and regulators demand evidence that digital therapeutics are safe, equitable, clinically meaningful, and auditable over time.

Key Regional Insights for Digital Therapeutics Adoption

North America remains a leading region for digital therapeutics commercialization due to advanced digital health infrastructure, payer experimentation, FDA precedent for prescription digital therapeutics, and employer demand for scalable chronic and behavioral health solutions. The United States is the primary commercialization engine, supported by remote therapeutic monitoring reimbursement codes and value-based care adoption, while Canada benefits from strong public health digitization, provincial virtual care initiatives, and growing attention to chronic disease management.

Europe is shaped by structured assessment and reimbursement models, particularly Germany’s DiGA program, France’s digital medical device reimbursement initiatives, the U.K.’s DTAC assessment framework, and broader EU emphasis on GDPR, medical device regulation, interoperability, and evidence-based software. Asia-Pacific is expanding as China, Japan, India, South Korea, and Australia invest in telehealth, mobile-first care, digital hospitals, and aging-population management. Latin America shows rising demand in diabetes, cardiovascular risk, mental health, and access-to-care use cases, with Brazil and Mexico acting as important adoption centers. The Middle East is accelerating through national digital health strategies in Gulf markets, where prevention, chronic care, and smart hospital programs are policy priorities. Africa remains earlier-stage but strategically important, with mobile health adoption, primary care access gaps, expanding broadband initiatives, and donor-supported digital health infrastructure creating long-term DTx opportunities.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are attractive for mobile-first digital therapeutics because smartphone penetration, urban healthcare demand, and public-private digital health initiatives are increasing across Singapore, Indonesia, Malaysia, Thailand, Vietnam, and the Philippines. Adoption is strongest where solutions support diabetes, cardiometabolic disease, mental health, respiratory care, and medication adherence while fitting local reimbursement, language, clinical workflow, and data residency requirements.

The European Union is advancing a rules-based DTx environment through GDPR, medical device regulation, health data space initiatives, cross-border interoperability priorities, and national reimbursement experiments. GCC countries are investing in digital health as part of economic diversification, preventive care strategies, and health system modernization, creating favorable conditions for digitally enabled chronic disease and behavioral health programs. BRICS markets represent scale, chronic disease burden, and cost-sensitive innovation potential, although regulatory heterogeneity, reimbursement fragmentation, and access disparities remain significant. G7 markets provide the deepest evidence, reimbursement, procurement, and clinical integration opportunities, while NATO countries overlap substantially with high-income digital health systems prioritizing cybersecurity, resilience, continuity of care, and trusted health data exchange.

Key Country Insights for Digital Therapeutics Growth

The United States leads in DTx commercialization, supported by FDA-recognized pathways for software-based medical interventions, CPT codes for remote therapeutic monitoring, established digital health procurement channels, and employer and payer interest in outcomes-based care. Canada is advancing virtual care and chronic disease management through provincial systems and national digital health collaboration, while Mexico and Brazil offer large populations, rising chronic disease needs, and growing private-sector demand for scalable digital health access.

In Europe, the United Kingdom’s NHS assessment frameworks, Germany’s DiGA reimbursement pathway, and France’s digital medical device reimbursement initiatives make these markets influential for evidence standards and procurement expectations. Italy and Spain are strengthening telehealth, electronic health records, and chronic care modernization, while Russia remains complex due to geopolitical, reimbursement, and procurement constraints. In Asia-Pacific, China offers scale and policy-driven digital health expansion, India provides mobile-first demand and substantial chronic disease needs, Japan prioritizes aging-related care, regulated quality, and clinical safety, Australia supports remote care across dispersed populations, and South Korea combines strong connectivity with advanced digital hospital ecosystems and government interest in smart healthcare.

Actionable Recommendations for Digital Therapeutics Leaders

Industry leaders should prioritize clinically validated use cases where digital therapeutics can demonstrate measurable outcomes, such as diabetes, hypertension, insomnia, substance use disorder, musculoskeletal care, respiratory disease, obesity, cardiovascular risk management, and behavioral health. Evidence strategies should combine randomized trials, real-world evidence, patient-reported outcomes, health economics, adherence metrics, safety monitoring, and subgroup analyses to support reimbursement and procurement.

Companies should also design for integration from the start. Interoperability with EHRs, remote monitoring devices, pharmacy systems, care management platforms, and clinician workflows improves adoption and reduces abandonment. Leaders should invest in privacy-by-design, cybersecurity, health equity testing, AI governance, accessibility, localization, and payer-aligned value propositions that translate engagement into reduced utilization, improved adherence, better quality measures, and sustained patient outcomes.

Research Methodology for Digital Therapeutics Analysis

A robust digital therapeutics research methodology should triangulate regulatory documents, peer-reviewed clinical evidence, payer policies, reimbursement codes, clinical practice guidelines, public health datasets, procurement activity, patent filings, product registries, and expert interviews. Market assessment should distinguish wellness apps from clinically validated DTx, software as a medical device, remote monitoring, connected disease management, and digital care navigation platforms to avoid category inflation.

The methodology should evaluate adoption by indication, care setting, business model, regulatory classification, evidence maturity, prescribing pathway, reimbursement readiness, and integration depth. Regional analysis should incorporate healthcare financing, data protection laws, physician adoption, smartphone access, digital literacy, language localization, procurement models, and health system priorities. AI-related analysis should review validation protocols, bias mitigation, post-market surveillance, model governance, explainability, algorithm change control, and clinical safety documentation.

Conclusion: Digital Therapeutics as a Core Healthcare Growth Market

Digital therapeutics are becoming a strategic layer of modern healthcare, connecting patients, clinicians, payers, and life sciences stakeholders through clinically guided software interventions. The market’s next phase will be defined less by app downloads and more by evidence, reimbursement, integration, cybersecurity, regulatory alignment, and sustained health outcomes.

Organizations that combine medical rigor with user-centered design, responsible AI, secure data practices, interoperability, and scalable partnerships will be best positioned to lead. As healthcare systems seek accessible, cost-effective, and personalized care models, digital therapeutics are set to play an expanding role in chronic disease management, behavioral health, preventive care, and digitally enabled population health.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.1.1. Build Around Reimbursed and Value-Linked Care Pathways
4.3.1.2. Convert Chronic-Care Capacity Gaps into Scalable Treatment Access
4.3.1.3. Use AI and Connected Interfaces to Personalize Therapy at Lower Marginal Cost
4.3.1.4. Scale Distribution Through Multi-Condition Platforms and Consolidation
4.3.2. Key Restraints
4.3.2.1. Reduce Evidence and Reimbursement Fragmentation Before Scaling
4.3.2.2. Close Engagement, Trust, and Digital-Access Gaps
4.3.3. Key Opportunities
4.3.3.1. Commercialize Prescription Digital Therapy Through Emerging Payment Routes
4.3.3.2. Expand Medication-Adjunct Therapy and Precision Stewardship
4.3.3.3. Localize Therapeutic Platforms for Asia-Pacific and Underserved Health Systems
4.3.4. Key Challenges
4.3.4.1. Industrialize Safe Change Control for AI-Enabled Therapy
4.3.4.2. Prove Incremental Value While Integrating Multi-Condition Care
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Digital Therapeutics Market, by Product Type

7.1. Introduction
7.2. Prescription Digital Therapeutics
7.3. Non-Prescription Digital Therapeutics
7.4. Software-Based Digital Therapeutics

8. Digital Therapeutics Market, by Technology

8.1. Introduction
8.2. Mobile Applications
8.3. Artificial Intelligence (AI) & Machine Learning
8.4. Remote Patient Monitoring
8.5. Internet of Medical Things (IoMT)

9. Digital Therapeutics Market, by Delivery Platform

9.1. Introduction
9.2. Smartphones
9.3. Tablets
9.4. Desktop/Laptop
9.5. Wearables

10. Digital Therapeutics Market, by Business Model

10.1. Introduction
10.2. Subscription-Based
10.3. Pay-Per-Use
10.4. One-Time License

11. Digital Therapeutics Market, by Application

11.1. Introduction
11.2. Diabetes
11.2.1. Type 1 Diabetes
11.2.2. Type 2 Diabetes
11.3. Mental Health & Behavioral Disorders
11.3.1. Depression
11.3.2. Anxiety
11.4. Oncology
11.4.1. Symptom Management
11.4.2. Treatment Adherence
11.5. Obesity & Weight Management
11.5.1. Weight Loss
11.5.2. Nutrition Management
11.6. Sleep Disorders
11.7. Disease Treatment
11.7.1. Respiratory Diseases
11.7.2. Cardiovascular Diseases

12. Digital Therapeutics Market, by Deployment Mode

12.1. Introduction
12.2. Cloud-Based
12.3. On-Premise
12.4. Hybrid

13. Digital Therapeutics Market, by End User

13.1. Introduction
13.2. Patients
13.3. Healthcare Providers
13.4. Pharmaceutical Companies
13.5. Research Organizations

14. Digital Therapeutics Market, by Region

14.1. North America
14.2. Europe
14.3. Asia-Pacific
14.4. Latin America
14.5. Africa
14.6. Middle East

15. Digital Therapeutics Market, by Group

15.1. NATO
15.2. G7
15.3. BRICS
15.4. European Union
15.5. ASEAN
15.6. GCC

16. Digital Therapeutics Market, by Country

16.1. United States
16.2. China
16.3. Canada
16.4. Germany
16.5. Brazil
16.6. Mexico
16.7. Japan
16.8. India
16.9. United Kingdom
16.10. France
16.11. South Korea
16.12. Australia
16.13. Russia
16.14. Italy
16.15. Spain

17. Competitive Landscape

17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025

18. Company Profiles

18.1. Hinge Health, Inc.
18.2. Sword Health Technologies, Inc.
18.3. Omada Health, Inc.
18.4. Teladoc Health, Inc.
18.5. Lark Technologies, Limited
18.6. Sidekick Health
18.7. Click Therapeutics, Inc.
18.8. Welldoc, Inc.
18.9. DarioHealth Corp.
18.10. Amalgam Rx, Inc.
18.11. Curio Digital Therapeutics, Inc.
18.12. Cognito Therapeutics, Inc.
18.13. BehaVR
18.14. Teva Pharmaceutical Industries Ltd.
18.15. Apple Inc.
18.16. Abbott Laboratories
18.17. OMRON Healthcare Co., Ltd.
18.18. Novo Nordisk A/S
18.19. Novartis AG
18.20. Google LLC by Alphabet Inc.
18.21. 2morrow Inc.
18.22. AptarGroup, Inc.
18.23. Big Health, Inc.
18.24. Biofourmis Inc.
18.25. Canary Health Technologies Inc.
18.26. Chugai Pharmaceutical Co., Ltd.
18.27. CogniFit Inc.
18.28. Cognoa, Inc.
18.29. CureApp, Inc.
18.30. Dexcom, Inc.
18.31. F. Hoffmann-La Roche Ltd
18.32. Fitterfly Healthtech Private Limited by PB Fintech Limited
18.33. GAIA AG by Ethypharm SAS
18.34. GET.ON Institut für Online-Gesundheitstrainings GmbH
18.35. Glooko, Inc.
18.36. Grünenthal GmbH
18.37. H2O Therapeutics Co.
18.38. Headspace Inc.
18.39. Hyfe, Inc.
18.40. Kaia Health Software Inc.
18.41. LifeScan, Inc.
18.42. Lumanity Inc.
18.43. Lumos Labs
18.44. MedRhythms
18.45. Noom, Inc.
18.46. ResMed, Inc.
18.47. SilverCloud by American Well Corporation
18.48. Vida Health, Inc.
18.49. Virtual Therapeutics Corp.

List of Figures

FIGURE 1. GLOBAL DIGITAL THERAPEUTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DIGITAL THERAPEUTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DIGITAL THERAPEUTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

List of Tables

TABLE 1. GLOBAL DIGITAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL PRESCRIPTION DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL PRESCRIPTION DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL PRESCRIPTION DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL NON-PRESCRIPTION DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL NON-PRESCRIPTION DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL NON-PRESCRIPTION DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SOFTWARE-BASED DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SOFTWARE-BASED DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SOFTWARE-BASED DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL MOBILE APPLICATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL MOBILE APPLICATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL MOBILE APPLICATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE (AI) & MACHINE LEARNING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE (AI) & MACHINE LEARNING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE (AI) & MACHINE LEARNING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL REMOTE PATIENT MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL REMOTE PATIENT MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL REMOTE PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL INTERNET OF MEDICAL THINGS (IOMT) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL INTERNET OF MEDICAL THINGS (IOMT) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL INTERNET OF MEDICAL THINGS (IOMT) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL SMARTPHONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SMARTPHONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SMARTPHONES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL TABLETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL DESKTOP/LAPTOP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL DESKTOP/LAPTOP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL DESKTOP/LAPTOP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL WEARABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL WEARABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL WEARABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SUBSCRIPTION-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SUBSCRIPTION-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SUBSCRIPTION-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL PAY-PER-USE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL PAY-PER-USE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL PAY-PER-USE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ONE-TIME LICENSE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL ONE-TIME LICENSE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL ONE-TIME LICENSE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL MENTAL HEALTH & BEHAVIORAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL MENTAL HEALTH & BEHAVIORAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL MENTAL HEALTH & BEHAVIORAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL DEPRESSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL DEPRESSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL DEPRESSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ANXIETY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ANXIETY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ANXIETY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SYMPTOM MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SYMPTOM MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SYMPTOM MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL TREATMENT ADHERENCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL TREATMENT ADHERENCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL TREATMENT ADHERENCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL OBESITY & WEIGHT MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL OBESITY & WEIGHT MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL OBESITY & WEIGHT MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL WEIGHT LOSS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL WEIGHT LOSS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL WEIGHT LOSS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL NUTRITION MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL NUTRITION MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL NUTRITION MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL SLEEP DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL SLEEP DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL SLEEP DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL DISEASE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL CLOUD-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL CLOUD-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL CLOUD-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ON-PREMISE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ON-PREMISE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL ON-PREMISE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL HYBRID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL HYBRID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL HYBRID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL PATIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL PATIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL PATIENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 135. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 137. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 138. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 139. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 140. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 141. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 142. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 143. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 144. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 145. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 146. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 147. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 164. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 166. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 167. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 168. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 169. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 170. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 171. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 172. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 175. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 176. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 177. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 178. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 179. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 180. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 181. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 182. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 183. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 184. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 185. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 186. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 187. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 188. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 189. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 200. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 201. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 202. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 203. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 204. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 205. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 206. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 207. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 208. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 209. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 210. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 211. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 212. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 213. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 214. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 215. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 216. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 217. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 218. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 219. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 220. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 221. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 222. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 223. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 224. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 225. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 226. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 228. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 229. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 230. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 231. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 232. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 233. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 234. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 235. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 236. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 237. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 238. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 239. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 253. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 254. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 255. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 256. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 257. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 258. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 259. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 260. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 261. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 262. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 263. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 264. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 265. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 267. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 268. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 269. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 270. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 271. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 273. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 274. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 275. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 276. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 277. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 278. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 279. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 280. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 281. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 282. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 283. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 284. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 293. CHINA DIGITAL THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 294. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 295. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 296. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 297. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 298. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 299. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 300. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 301. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 302. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 303. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 304. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 305. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 306. CANADA DIGITAL THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 307. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 308. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 309. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 310. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 311. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 312. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 313. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 314. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 315. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 316. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 317. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 318. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 319. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 320. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 321. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 322. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 323. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 324. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 325. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 326. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 327. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 328. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 329. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 330. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 331. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 332. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 333. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 334. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 335. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 336. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 337. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 338. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 339. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 340. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 341. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY & WEIGHT MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 342. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 343. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 344. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 345. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 346. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 347. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 348. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY DELIVERY PLATFORM, 2017-2032 (USD MILLION)
TABLE 349. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 350. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 351. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 352. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY MENTAL HEALTH & BEHAVIORAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 353. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 354. MEXICO DIGITAL THERAPEUTICS MARKET SIZE

Companies Mentioned

Hinge Health, Inc.
Sword Health Technologies, Inc.
Omada Health, Inc.
Teladoc Health, Inc.
Lark Technologies, Limited
Sidekick Health
Click Therapeutics, Inc.
Welldoc, Inc.
DarioHealth Corp.
Amalgam Rx, Inc.
Curio Digital Therapeutics, Inc.
Cognito Therapeutics, Inc.
BehaVR
Teva Pharmaceutical Industries Ltd.
Apple Inc.
Abbott Laboratories
OMRON Healthcare Co., Ltd.
Novo Nordisk A/S
Novartis AG
Google LLC by Alphabet Inc.
2morrow Inc.
AptarGroup, Inc.
Big Health, Inc.
Biofourmis Inc.
Canary Health Technologies Inc.
Chugai Pharmaceutical Co., Ltd.
CogniFit Inc.
Cognoa, Inc.
CureApp, Inc.
Dexcom, Inc.
F. Hoffmann-La Roche Ltd
Fitterfly Healthtech Private Limited by PB Fintech Limited
GAIA AG by Ethypharm SAS
GET.ON Institut für Online-Gesundheitstrainings GmbH
Glooko, Inc.
Grünenthal GmbH
H2O Therapeutics Co.
Headspace Inc.
Hyfe, Inc.
Kaia Health Software Inc.
LifeScan, Inc.
Lumanity Inc.
Lumos Labs
MedRhythms
Noom, Inc.
ResMed, Inc.
SilverCloud by American Well Corporation
Vida Health, Inc.
Virtual Therapeutics Corp.

Table Information

Report Attribute	Details
No. of Pages	189
Published	August 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 7.37 Billion
Forecasted Market Value ( USD ) by 2032	$ 18.05 Billion
Compound Annual Growth Rate	15.9%
Regions Covered	Global
No. of Companies Mentioned	49

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3184EUR$3,545USD£2,720GBP €3538EUR$3,939USD£3,022GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4817EUR$5,363USD£4,115GBP €5352EUR$5,959USD£4,572GBP

Transformative Shifts in the Digital Therapeutics Landscape

Cumulative Impact of Artificial Intelligence on Digital Therapeutics

Key Regional Insights for Digital Therapeutics Adoption

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Key Country Insights for Digital Therapeutics Growth

Actionable Recommendations for Digital Therapeutics Leaders

Research Methodology for Digital Therapeutics Analysis

Conclusion: Digital Therapeutics as a Core Healthcare Growth Market

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Digital Therapeutic Devices Market - Global Forecast 2026-2032

Digital Therapeutics Market (By Component, Application, End User, Region), Company Profiles, Recent Developments, Market Dynamics - Growth Trends and Forecast (2025-2032)

Digital Therapeutics for Tinnitus Market Report 2026

Digital Therapeutics - Global Strategic Business Report

Digital Therapeutics Market Report by Application, End Use, and Region 2026-2034